ClinicalTrials.Veeva

Menu

Protocolised Management of Phosphate Replacement Trial (PROMPT)

C

Caboolture Hospital

Status

Not yet enrolling

Conditions

Protocol Optimization
Hypophosphatemia
Phosphate Deficiency
Critical Care, Intensive Care

Treatments

Other: Restrictive Phosphate Replacement Protocol
Other: Liberal Phosphate Replacement Protocol

Study type

Interventional

Funder types

Other

Identifiers

NCT07288944
HREC/2025/MNH/121108

Details and patient eligibility

About

The aim of this cluster, crossover, randomised controlled trial is to compare two standard arms of treatment for the replacement of phosphate in critically ill patients.

We hypothesise that protocolised restricted phosphate replacement, compared to protocolised liberal phosphate replacement, will result in reduced administration of phosphate with similar clinical outcomes.

All eligible Intensive Care Unit (ICU) patients will be included during their admission with the selected protocol for that period as per usual practice and treatment standards.

Full description

This study looks to compare liberal and restrictive phosphate replacement protocols (each arm is a current "standard of care" already used in practice) to investigate whether restrictive phosphate replacement in critically ill patients leads to reduced phosphate administration and/or equivalent patient outcomes.

Derangements of serum phosphate concentrations are common among ICU patients; high and low levels variably associated with worse outcomes. The PROMPT trial will compare two standard arms of treatment for the replacement of phosphate in critically ill patients. Phosphate is currently replaced routinely in ICU's however there is not a standardised evidence-based guideline to effectively guide phosphate administration for ICU patients

This is a cluster, crossover, electronic medical record integrated, randomised, controlled trial. Sites (not patients) will be randomised to wither the liberal or restrictive phosphate replacement protocol for a 6-month period, followed by a 1-month washout period, before switching to the next protocol for the preceding 6-month period. The allocated phosphate replacement protocol will be updated in the electronic medical record to be followed; this process is already part of normal clinical practice.

Enrollment

2,400 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All adult patients admitted to participating intensive care units during the study period.

Exclusion criteria

  • There will be no specific exclusion criteria

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

2,400 participants in 2 patient groups

Liberal Phosphate Replacement Protocol
Active Comparator group
Description:
The liberal group, a recommendation for phosphate replacement would be given if the serum phosphate concentration was 0.79 mmol/L, but not if 0.80 mmol/L.
Treatment:
Other: Liberal Phosphate Replacement Protocol
Conservative Phosphate Replacement Protocol
Active Comparator group
Description:
The restrictive protocol will recommend phosphate replacement to commence at a threshold of 0.50 mmol/L, and the liberal protocol at 0.80 mmol/L.
Treatment:
Other: Restrictive Phosphate Replacement Protocol

Trial contacts and locations

0

Loading...

Central trial contact

Mahesh Ramanan; Emma L Williams

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems